Lexeo Therapeutics Inc (LXEO)

SG&A Expense Growth

43.52%

Fiscal year · Period ending:

LXEO logo

LXEO SG&A Expense Growth

Latest reported43.52%
LXEO FY SG&A Growth (YoY) (0.00% → 43.52%)
High-resolution chart · PNG

LXEO sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Lexeo Therapeutics Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
43.5201%
105.9091%
28.181%
67.308%
810.8583%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.